Ilise Lombardo, MD

Ilise Lombardo, MD

President, Therapeutics

  • Bio
    Ilise Lombardo is the Chief Medical Officer at Kriya Therapeutics. Prior to joining Kriya, Dr. Lombardo was co-founder of Arvelle Therapeutics B.V. a European pharmaceutical company focused on epilepsy which was subsequently sold to Angelini Pharma. Through her work at Arvelle, Dr. Lombardo was named one of the top 10 female company founders globally. Prior to founding Arvelle, Dr. Lombardo has held senior roles in Clinical Development and Medical Affairs working with small molecules, biologics and gene therapies at Axovant Sciences, Forum Pharmaceuticals, and Pfizer. She has built and led successful teams across multiple therapeutic areas including CNS, Ophthalmology, Pulmonary Vascular Disease, Rare Diseases, and Endocrine Care. Prior to her work in the pharmaceutical industry, Dr. Lombardo was on the Faculty of Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, where she previously had completed her residency in Psychiatry. She completed two fellowships, one in neuroreceptor imaging at Columbia University and one in molecular genetics jointly at Yale University and the University of Cambridge in the lab of Nobel Laureate Sydney Brenner. She received her MD from Yale University, an M.Phil from the University of Cambridge and undergraduate degree in philosophy from Brown University.